Early detection RCE.ai focuses on non-invasive, AI-driven early detection of heart attack using a transdermal infrared wearable, presenting a sales angle around enabling hospital emergency departments and remote monitoring programs to deploy cutting-edge diagnostic tech.

Clinical validation There are ongoing clinical studies to optimize the product for clinical use, signaling opportunities to collaborate with research centers, hospitals, and KOLs for joint studies, real-world evidence, and potential inclusion in clinical pathways once regulatory approval progresses.

Regulatory gap The technology is not yet FDA approved and not available for sale in the US, highlighting a sales window in markets with regulatory readiness or through partnership/licensing models that can prepare for US approval and eventual commercialization.

Remote care synergy The wearable and AI platform are positioned for emergency care and remote monitoring, suggesting cross-sell opportunities with telehealth providers, home health programs, and hospital-at-home initiatives seeking continuous cardiac monitoring capabilities.

Tech and cloud stack Utilizes cloud and modern tech stack (AWS, Google Cloud, Sentry) and consumer-friendly web platforms (Wix, WordPress) which can ease integration, pilot deployments, and rapid onboarding for partners seeking scalable AI-enabled medical devices.